Abstract
Purpose
This study aimed to determine the survival outcome and prognostic factors of patients with nasopharyngeal cancer accessing treatment in Yogyakarta, Indonesia.
Methods
Data on 759 patients with NPC diagnosed from 2007 to 2016 at Dr Sardjito General Hospital were included. Potential prognostic variables included sociodemographic, clinicopathology and treatment parameters. Multivariable analyses were implemented using semi-parametric Cox proportional hazards modelling and fully parametric survival analysis.
Results
The median time of observation was 14.39 months. In the whole cohort the median observed survival was 31.08 months. In the univariable analysis, age, education status, insurance type, BMI, ECOG index, stage and treatment strategy had an impact on overall survival (OS) (p values <0.01). Semi-parametric multivariable analyses with stage stratification showed that education status, ECOG index, and treatment modality were independent prognostic factors for OS (p values <0.05). In the fully parametric models age, education status, ECOG index, stage, and treatment modality were independent prognostic factors for OS (p values <0.05). For both multivariable analyses, all treatment strategies were associated with a reduced hazard (semi-parametric models, p values <0.05) and a better OS (parametric models, p values <0.05) compared with no treatment. Furthermore, compared with radiation alone or chemotherapy alone, a combination of chemotherapy and radiation either in a form of concurrent chemoradiotherapy (CCRT), sequential chemotherapy and radiation, or induction chemotherapy followed by CCRT demonstrated a reduced hazard (hazard ratio/HR 0.226, 95% confidence interval/CI 0.089–0.363, and HR 0.390, 95%CI 0.260–0.519) and a better OS (time ratio/TR 3.108, 95%CI 1.274–4.942 and TR 2.531, 95%CI 1.829–3.233) (p values < 0.01).
Conclusions
Median OS for the cohort was low compared to those reported in both endemic and non-endemic regions. By combining the findings of multivariable analyses, we showed that age, education status, ECOG index, stage and first treatment modality were independent predictors for the OS.
Funder
KWF Kankerbestrijding
The Indonesian Society for Hematology and Medical Oncology Yogyakarta Branch
Universitas Gadjah Mada’s Publisher and Publication Board
Publisher
Public Library of Science (PLoS)
Reference63 articles.
1. The enigmatic epidemiology of nasopharyngeal carcinoma;ET Chang;Cancer Epidemiol Biomarkers Prev,2006
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F Bray;CA Cancer J Clin,2018
3. Treatment outcome for nasopharyngeal carcinoma in University Malaya Medical Centre from 2004–2008;V Chee Ee Phua;Asian Pacific Journal of Cancer Prevention: APJCP,2013
4. Nasopharyngeal carcinoma;MLK Chua;The Lancet,2016
5. High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island;BC Devi;Cancer Epidemiol Biomarkers Prev,2004